国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2014年
2期
186-187
,共2页
吴立春%宋晓玉%张珂%曹鸣菲
吳立春%宋曉玉%張珂%曹鳴菲
오립춘%송효옥%장가%조명비
肝炎抗体,丙型%肿瘤%输血%酶联免疫吸附测定
肝炎抗體,丙型%腫瘤%輸血%酶聯免疫吸附測定
간염항체,병형%종류%수혈%매련면역흡부측정
hepatitis C antibodies%neoplasm%blood transfusion%enzyme-linked immunosorbent assay
目的:了解肿瘤医院住院患者中丙型肝炎病毒(HCV)的感染状况。方法对本院2008年1月至2012年12月期间的住院患者用酶联免疫吸附法(ELISA)检测血清 HCV 抗体,筛选出 HCV 抗体阳性患者相关资料进行回顾性分析。结果从67438例患者中检出 HCV抗体阳性327例,其中40~59岁龄段的占53.21%,男女比例为1.11∶1.00,科室分布以肝胃病区为主,2011年检出率最低为4.24‰,2008年检出率最高为5.95‰,病种以肝癌最多,占23.28%。结论肿瘤患者丙肝抗体阳性率低于一般人群、年龄跨度大、科室分布广、肿瘤谱宽。因此,对患者术前、输血前和各种创伤侵袭性操作前应该对其进行 HCV 常规检查,以防止院内感染的发生。
目的:瞭解腫瘤醫院住院患者中丙型肝炎病毒(HCV)的感染狀況。方法對本院2008年1月至2012年12月期間的住院患者用酶聯免疫吸附法(ELISA)檢測血清 HCV 抗體,篩選齣 HCV 抗體暘性患者相關資料進行迴顧性分析。結果從67438例患者中檢齣 HCV抗體暘性327例,其中40~59歲齡段的佔53.21%,男女比例為1.11∶1.00,科室分佈以肝胃病區為主,2011年檢齣率最低為4.24‰,2008年檢齣率最高為5.95‰,病種以肝癌最多,佔23.28%。結論腫瘤患者丙肝抗體暘性率低于一般人群、年齡跨度大、科室分佈廣、腫瘤譜寬。因此,對患者術前、輸血前和各種創傷侵襲性操作前應該對其進行 HCV 常規檢查,以防止院內感染的髮生。
목적:료해종류의원주원환자중병형간염병독(HCV)적감염상황。방법대본원2008년1월지2012년12월기간적주원환자용매련면역흡부법(ELISA)검측혈청 HCV 항체,사선출 HCV 항체양성환자상관자료진행회고성분석。결과종67438례환자중검출 HCV항체양성327례,기중40~59세령단적점53.21%,남녀비례위1.11∶1.00,과실분포이간위병구위주,2011년검출솔최저위4.24‰,2008년검출솔최고위5.95‰,병충이간암최다,점23.28%。결론종류환자병간항체양성솔저우일반인군、년령과도대、과실분포엄、종류보관。인차,대환자술전、수혈전화각충창상침습성조작전응해대기진행 HCV 상규검사,이방지원내감염적발생。
Objective To investigate the HCV infection condition of patients in tumor hospital.Methods ELISA was used to detect the HCV antibody in the blood sera of inpatients in the tumor hospital during January 2008 to December 2012,and the infor-mation about the positive results were analyzed with retrospective analysis.Results 327 positive serums HCV antibody were found among 67 438 individuals,the patients with age between 40 and 59 years accounted for 53.21%,and male and female ratio was 1 .1 1:1 .00 .Patients with HCV antibody were mainly found in hepatobiliary &gastrointestinal surgical department.The lowest de-tection rate was 4.24% in 2011 and the highest detection rate was 5.95% in 2008.The main disease was liver cancer,accounted for 23.28%.Conclusion The positive rate of anti-HCV in patients with tumors might be lower than normal crowd,and the distribution of department,age and tumor types are becoming wide.So all patients before surgery,blood transfusion and all kinds of traumatic or intrusion inspection should take HCV detection.